Country: United States
Language: English
Source: NLM (National Library of Medicine)
CYCLOSPORINE (UNII: 83HN0GTJ6D) (CYCLOSPORINE - UNII:83HN0GTJ6D)
DR MARC'S MANUFACTURING AND SALES
CYCLOSPORINE
CYCLOSPORINE 0.0005 g in 100 mL
PRESCRIPTION DRUG
unapproved drug other
HYDRO-STASIS- CYCLOSPORINE-A LIQUID DR MARC'S MANUFACTURING AND SALES _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- USE: FOR TOPICAL APPLICATION TO THE EYE. ACTIVE: CYCLOSPORINE-A 5 PPM USUAL DOSAGE: INSTILL ONE DROP TWICE DAILY IN EACH EYE, APPROXIMATELY 12 HOURS APART. INACTIVES: GLYCERIN USP, PROPYLENE GLYCOL USP, CELLULOSE, WATER, PRESERVATIVE STORAGE: STORE AT 15-25°C (59-77°F) HYDRO-STASIS cyclosporine-a liquid DR MARC'S MANUFACTURING AND SALES PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:70 414-20 2 ROUTE OF ADMINISTRATION OPHTHALMIC ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH CYCLO SPO RINE (UNII: 8 3HN0 GTJ6 D) (CYCLOSPORINE - UNII:8 3HN0 GTJ6 D) CYCLOSPORINE 0 .0 0 0 5 g in 10 0 mL INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH GLYCERIN (UNII: PDC6 A3C0 OX) PRO PYLENE GLYCO L (UNII: 6 DC9 Q16 7V3) PO WDERED CELLULO SE (UNII: SMD1X3XO9 M) WATER (UNII: 0 59 QF0 KO0 R) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:70 414-20 2- 11 10 mL in 1 BOTTLE, DROPPER; Type 0 : No t a Co mbinatio n Pro duc t 0 7/13/20 17 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 0 2/23/20 16 LABELER - DR MARC'S MANUFACT URING AND SALES (084006446) Revised: 9/2017 Read the complete document